Trade Bristol Myers BMY

Sell
 Buy

BristolMyers live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

BristolMyers News

Emma Rose 2025 Aug 15, 00:00

Alaska Summit Analysis: Will Putin Outmaneuver Trump on Ukraine?

Noah Lee 2025 Aug 15, 00:00

Trump's Pressure on Economic Data: A False Calm Before the Storm?

Emma Rose 2025 Aug 15, 00:00

Gold Price Outlook: Inflation, Debt, and Currency Devaluation Fuel Demand

Ghko B 2025 Aug 14, 16:00

AMD Stock Is down Today: What Happened to Advanced Micro Devices Inc?

stocks
Ghko B 2025 Aug 14, 16:00

Crypto market today: Trump Supports Cryptos, BTC/USD over $119K

crypto
Ghko B 2025 Aug 14, 16:00

What is VOO: how to trade Vanguard S&P 500 ETF CFD with markets.com?

etfs cfd trading
Magnificent 7 earnings, US and Japan inflation due next week
Neil Wilson 2024 Jul 18, 16:00

Week ahead: Magnificent 7 earnings, 2 key inflation reports

Forex Indices
Wall Street earnings
Neil Wilson 2023 Oct 20, 10:00

Week ahead: Earnings bonanza, ECB decision & US inflation

Forex Indices
Megacap-tech-stocks.jpg
Neil Wilson 2023 Apr 21, 05:00

Week ahead: Megacap tech and 1-in-3 Dow components set to report

2022 Jul 24, 05:42

Week ahead: Fed to hike 100bps into a recession?

Latest news

Show more
Emma Rose 2025 Aug 15, 00:00

Fed Rate Cut Uncertainty Looms: Powell Navigates Rising Pressure

Liam James 2025 Aug 15, 00:00

Bitcoin and Ethereum Surge to New Highs Amidst Market Optimism

Sophia Claire 2025 Aug 15, 00:00

US Treasury Secretary Bessent Defends Fed Rate Cut Comments, Citing Model Suggestion

Noah Lee 2025 Aug 15, 00:00

Fundstrat Bullish on Ethereum: Growth Drivers and Price Predictions

Frances Wang 2025 Aug 14, 16:00

Stock market today: FTSE 100, DAX 30, CAC 40, Nikkei 225

Indices
Frances Wang 2025 Aug 14, 16:00

Shiba Inu Coin News: What’s Going on With Shiba Coin?

Cryptocurrencies
Liam James 2025 Aug 14, 00:00

US Interest Rate Cut Debate Heats Up: Will September See Action?

Emma Rose 2025 Aug 14, 00:00

Easing Sanctions on Russia: A Delicate Balance Between Ceasefire and European Interests

Info

Spread

0.31

Spread (%)

0.6416 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

13:31 - 19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

97314390016

Shares Outstanding

2035440000

Earnings Date (Next)

2001-08-07

Div Yield

2025-08-01

Ex-Dividend Date

2025-07-03

Forward annual dividend rate

2.48

Forward annual dividend yield

0.0518

EPS

2.49

Learn more about this instrument

Bristol Myers Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel to treat patients with Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of relapsed/refractory multiple myeloma; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Reblozyl to treat anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Cobenfy to treat schizophrenia in adults; Krazati for the treatment of adult patients with KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); Camzyos to treat symptomatic obstructive HCM to improve functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug to treat multiple myeloma; and Abraxane for the treatment of breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Frances Wang 2025 Aug 14, 16:00

Stock CFD Trading Online: DJT Stock CFD, RIVN Stock CFD, PLTR Stock CFD

Shares CFD Trading
Ghko B 2025 Aug 14, 16:00

Best Stocks for Beginners: How to Trade Stock CFDs with markets.com?

Stocks
Ghko B 2025 Aug 14, 16:00

How to Invest in Forex: 2025 Beginner's Guide for Forex CFD Trading

Forex CFD Trading
Trustpilot